| Literature DB >> 33574905 |
Luca Nicosia1, Antuono Latronico1, Mariagiorgia Farina1, Anna Carla Bozzini1, Paola Baratella2, Viviana Enrica Galimberti2, Stefano Fiori3, Marta Montesano4, Enrico Cassano1.
Abstract
Myeloid sarcoma (MS) is a rare neoplasm, represented by a tumoural mass composed of myeloid blasts, occurring at any anatomical site other than the bone marrow. MS is considered the tissue-based equivalent of acute myeloid leukaemia (AML), requiring the same therapeutic specification, independently from the association with previous or coexisting myeloid neoplasms. Isolated breast involvement by MS is exceedingly rare, with only exceptional cases reported in the literature. This work aims to provide a pictorial essay of the main features of breast involvement by MS. Even though it is a rare condition, we should not forget this neoplasm, and its possibility of being disguised by the AML, as it requires prompt treatment. © the authors; licensee ecancermedicalscience.Entities:
Keywords: biopsy; breast; breast cancer; myeloid sarcoma
Year: 2020 PMID: 33574905 PMCID: PMC7864689 DOI: 10.3332/ecancer.2020.1160
Source DB: PubMed Journal: Ecancermedicalscience ISSN: 1754-6605